Michael L. Goris
Publication Details
-
Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis.
Chest. 2005; (4): 2327-35
To evaluate quantitative air trapping measurements in children with mild cystic fibrosis (CF) lung disease during a 1-year, double-blind, placebo-controlled, recombinant human deoxyribonuclease (rhDNase) [dornase alfa] intervention trial and compare results from quantitative air trapping with those from spirometry or visually scored high-resolution CT (HRCT) scans of the chest.
Help